site stats

Rsls earnings

WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/792,094, … WebReShape Lifesciences® To Delay Year Ended December 31, 2024 Earnings Release and Conference Call. SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS ...

RSLS ReShape Lifesciences Inc. Analyst Estimates

WebMar 23, 2024 · ReShape Lifesciences Inc. (RSLS) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50) … danish porcelain hallmarks https://anywhoagency.com

RSLS Stock Forecast, Price & News (ReShape Lifesciences) - MarketBeat

WebReShape Lifesciences Inc. analyst estimates, including RSLS earnings per share estimates and analyst recommendations. Web29 rows · Mar 17, 2024 · ReShape Lifesciences (OTCMKTS:RSLS) has a recorded net income of -$61.93 million. RSLS has ... birthday card with cricut

RSLS - Reshape Lifesciences Stock Price - Barchart.com

Category:RSLS ReShape Lifesciences Inc. Financial Statements - WSJ

Tags:Rsls earnings

Rsls earnings

ReShape Lifesciences (RSLS) Earnings Date & Reports

WebApr 11, 2024 · Gross Revenue: Price/Sales Ratio: Net Income: Earnings Per Share: Price/Earnings Ratio: ReShape Lifesciences: $13.60 million: 0.10-$61.93 million ($197.50)-0.01 WebCurrent and historical p/e ratio for ReShape Lifesciences (RSLS) from 2015 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Rsls earnings

Did you know?

WebRSLS Stock Price - ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. ... It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. ReShape Lifesciences Inc.'s EBITDA is -0.03. WebNext quarter’s earnings estimate for RSLS is -$10.00 with a range of -$10.50 to -$9.50. The previous quarter’s EPS was -$29.25. RSLS beat its EPS estimate 0.00% of the time in the …

Weba. Analysing RSLS's past stock price performance after earnings announcements. b. Evaluating demand and supply activities around RSLS's earnings. c. Studying the company's fundamentals. d. Keeping track of peer companies and the price changes that happen after earnings releases in the same quarter as RSLS’s scheduled announcements. WebAug 5, 2024 · For the three months ended June 30, 2024, the Company reported revenues of $3.5 million, as compared to revenues of $1.7 million in the three months ended June 30, 2024, representing a 107%...

WebApr 8, 2024 · Third quarter 2024 earnings released: US$0.60 loss per share (vs US$1.48 loss in 3Q 2024) Nov 16 See more updates Shareholder Returns See full shareholder returns Return vs Industry: RSLS underperformed the US Medical Equipment industry which returned -13.6% over the past year. WebApr 12, 2024 · ReShape Lifesciences Inc. (OTCMKTS:RSLS) released its quarterly earnings data on Thursday, August, 13th. The medical device company reported ($0.17) earnings per share for the quarter, topping the …

WebApr 14, 2024 · RSLS ReShape Lifesciences Inc. Stock Price & Overview $2.59 -0.19 ( -6.68%) 3:39 PM 03/17/23 NASDAQ $USD Delayed Summary Ratings Financials Earnings …

WebApr 6, 2024 · Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecasts finance.yahoo.com - March 31 at 3:53 PM: ReShape Lifesciences Inc. (RSLS) uk.finance.yahoo.com - March 28 at 11:03 PM: ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M seekingalpha.com - March 28 at … birthday card with labrador dogWebMar 31, 2024 · earnings-and-revenue-growth Following the latest results, ReShape Lifesciences' twin analysts are now forecasting revenues of US$18.9m in 2024. This would be a huge 39% improvement in sales... birthday card with guitar themeWebApr 3, 2024 · RSLS: EnteroMedics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. RSLS: EnteroMedics - Detailed Earnings … danish porcelain companiesWebApr 6, 2024 · RSLS Stock Chart & Stats Advanced Chart > $2.75 $0.06 (2.23%) At close: Apr 06 4:00 PM EDT ― Day’s Range $0 - $0 52-Week Range $2.49 - $63.00 Previous Close $2.75 Volume 86.63K Average Volume (3M) 637.23K Market Cap $1.40M Enterprise Value -$4.49M Total Cash (Recent Filing) $6.15M Total Debt (Recent Filing) $255.00K Price to Earnings … danish porcelain plate clocksWebMar 28, 2024 · RSLS 24O0 SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. ( Nasdaq: RSLS ), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will delay its year ended December 31, 2024 earnings release and conference call, previously scheduled for 8:00 … birthday card with own photoWeb8 rows · ReShape Lifesciences Inc. (RSLS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W ... birthday card with name and photo generatorWebApr 10, 2024 · Reshape Lifesciences Inc (NASDAQ:RSLS) Q4 earnings in 5 days from now on Wed Mar, 29th before market open Conference call scheduled in 5 days at 8:00 AM Click … birthday card with gift